Key Developments: Rhoen Klinikum AG (RHKG.DE)

RHKG.DE on Xetra

23.48EUR
30 Jan 2015
Change (% chg)

€-0.08 (-0.32%)
Prev Close
€23.56
Open
€23.56
Day's High
€23.90
Day's Low
€23.38
Volume
188,416
Avg. Vol
440,539
52-wk High
€24.87
52-wk Low
€21.75

Search Stocks

Latest Key Developments (Source: Significant Developments)

Rhoen Klinikum AG further confirms FY 2015 outlook
Friday, 7 Nov 2014 01:00am EST 

Rhoen Klinikum AG:Continues to adhere to mid-term outlook with revenues of 1.06 billion euros to 1.12 billion euros and earnings before interest, taxes, depreciation and amortization (EBITDA) of between 145 million euros and 155 million euros for FY 2015.FY 2015 revenue estimate 1.102 billion euros - Thomson Reuters I/B/E/S.FY 2015 EBITDA estimate 148.15 million euros - Thomson Reuters I/B/E/S.  Full Article

Rhoen Klinikum AG implements share repurchase 2014
Tuesday, 14 Oct 2014 03:36pm EDT 

Rhoen Klinikum AG:Says management board resolved to make public repurchase offer for repurchase of up to 65,813,330 shares outside stock exchange.Says offer price per share (excluding ancillary purchase costs) paid by company amounts to 25.18 euros.Says tender ratio for this repurchase offer is 21:10, ownership of 21 shares thus entitles shareholder to accept repurchase offer for 10 shares.Baader Bank AG to be financial institution accompanying share repurchase.  Full Article

Rhoen Klinikum AG reaches settlement of law suits against resolutions of AGM 2014
Monday, 29 Sep 2014 02:06pm EDT 

Rhoen Klinikum AG:Says reached settlement of law suits against resolutions of the annual general meeting 2014 on appropriation of profits and capital reduction/share repurchase 2014.Says company on the one hand and Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG on the other agreed to a settlement proposal of the Higher Regional Court of Nuernberg.Law suits filed by Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG regarding the election of Ludwig Georg Braun as member of the supervisory board remain unaffected by the aforementioned settlement.  Full Article

Rhoen Klinikum AG confirms FY 2015 outlook - Conference Call
Friday, 8 Aug 2014 07:30am EDT 

Rhoen Klinikum AG:Confirms FY 2015 outlook.Expects FY 2015 revenue between 1,060 mln Euros and 1,120 mln Euros.Expects FY 2015 EBITDA between 145 mln Euros and 155 mln Euros.  Full Article

Rhoen Klinikum AG says law suit has been filed against Annual General Meeting vote
Tuesday, 15 Jul 2014 11:14am EDT 

Rhoen Klinikum AG:Says law suit has been filed against vote at AGM regarding appropriation of balance sheet profits and share repurchase.Says law suit has also been filed against election of Ludwig Georg Braun as member of the supervisory board.Says considers the challenged resolutions to be lawful and intends to defend itself against the law suit.  Full Article

Rhoen Klinikum AG confirms FY 2015 outlook
Wednesday, 14 May 2014 01:00am EDT 

Rhoen Klinikum AG:Confirms the FY 2015 outlook.Expects revenues of 1.06 billion to 1.12 billion euros and earnings before interest, tax, depreciation and amortization (EBITDA) of between 145 million and 155 million euros for FY 2015.FY 2015 revenues at 1,100 mln euros-Thomson Reuters I/B/E/S.  Full Article

Rhoen Klinikum AG issues FY 2015 outlook below analysts' estimates
Wednesday, 12 Mar 2014 08:00pm EDT 

Rhoen Klinikum AG:Expects revenues of 1.06 to 1.12 billion euro and earnings before interest, tax, depreciation and amortisation (EBITDA) of between 145 and 155 million euros for FY 2015, first full financial year with new corporate structure.FY 2015 revenue estimate 3.065 billion euros - Thomson Reuters I/B/E/S.FY 2015 EBITDA estimate 405.78 million euros - Thomson Reuters I/B/E/S.  Full Article

German Cartel Office grants merger control clearance to Rhoen Klinikum AG for transaction with Fresenius/HELIOS
Thursday, 20 Feb 2014 07:18am EST 

Rhoen Klinikum AG:Announces that the German Cartel Office, granted merger control clearance for the transaction with Fresenius/HELIOS without restrictions and conditions.The merger control clearance comprises 40 clinics, medical centers and related companies and thus the entire sold portfolio except for the clinics in Cuxhaven, Waltershausen-Friedrichroda und Boizenburg and two management companies for medical centers.The excepted companies were, in coordination with the Cartel Office, removed from the sold portfolio already prior to the merger control clearance.The cleared transaction will for the most part be closed until end of Feb. by payment of the purchase price and transfer of the shares.  Full Article

Rhoen Klinikum AG announces that three hospitals will remain for merger control reasons
Monday, 27 Jan 2014 04:48am EST 

Rhoen Klinikum AG:Announces that the hospitals in Cuxhaven, Waltershausen-Friedrichroda and Boizenburg have been removed from the application to the German Bundeskartellamt (Independent Competition Authority) following a current evaluation of merger control aspects for the entire transaction.Says facilities will not transfer to Fresenius / Helios but will initially remain with the Rhoen Klinikum AG.Says this also applies to a number of medical care centre (MVZ) companies which are connected to the above hospitals either for regional reasons or through their corporate concept.  Full Article

Rhoen Klinikum AG Sells 43 Hospitals, Medical Centers and Related Holdings to HELIOS Kliniken GmbH
Thursday, 12 Sep 2013 06:52pm EDT 

Rhoen Klinikum AG announced that RHOEN-KLINIKUMS AG ('RHOEN'), HELIOS Kliniken GmbH ('HELIOS') and Fresenius SE & CO. KGaA have entered into a share purchase agreement that stipulates the sale of a portfolio consisting of 43 hospitals, medical centers and related holdings from RHOEN to HELIOS and related companies ('Transaction'). In the context of the transaction RHOEN and HELIOS enter into an additional network-agreement in order to enable the establishment of regional and supra-regional networks for the further development of the market for hospitals in Germany. This includes the provision of additional medical care services. While HELIOS agrees to invest EUR 30 million in this network, RHOEN will invest EUR 10 million within the next five years. RHOEN's hospitals located in Bad Neustadt, Bad Berka, Frankfurt (Oder), as well as the university hospitals Gie├čen and Marburg are excluded from the Transaction. The purchase price amounts to EUR 3.070 billion (enterprise value) before adjustments resulting from specific cash and debt items. The supervisory boards of both companies have approved the transaction. Approval of the general meeting is not required.  Full Article

Asklepios hikes stake in Rhoen-Klinikum to 15.25 percent

FRANKFURT, Nov 24 - Unlisted German hospitals chain Asklepios' stake in Rhoen-Klinikum has increased to 15.25 percent from less than 10 percent, a regulatory filing by Rhoen showed on Monday.

Search Stocks